ACM Research insider sells 140,000 shares
Director, officer, and ten percent owner David H. Wang exercised options and sold 140,000 ACMR shares over two days under a Rule 10b5-1 trading plan.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
ACM Research, Inc. (ACMR) reported that director, officer, and ten percent owner David H. Wang exercised options to acquire a total of 140,000 shares of Class A Common Stock at an exercise price of $1.00 per share on September 8 and 9, 2026, and sold 140,000 shares of Class A Common Stock in multiple open-market transactions on those same dates under a Rule 10b5-1 trading plan adopted on June 5, 2026.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option F11 | 70,000 | $0.00 | $0.00 |
| Exercise | Class A Common Stock | 70,000 | $1.00 | $70K |
| Sale | Class A Common Stock F1, F6 | 33,493 | $73.80 | $2.47M |
| Sale | Class A Common Stock F1, F7 | 18,934 | $74.67 | $1.41M |
| Sale | Class A Common Stock F1, F8 | 11,666 | $75.58 | $882K |
| Sale | Class A Common Stock F1, F9 | 4,807 | $76.73 | $369K |
| Sale | Class A Common Stock F1, F10 | 1,100 | $77.59 | $85K |
| Exercise | Stock Option F11 | 70,000 | $0.00 | $0.00 |
| Exercise | Class A Common Stock | 70,000 | $1.00 | $70K |
| Sale | Class A Common Stock F1, F2 | 4,803 | $75.99 | $365K |
| Sale | Class A Common Stock F1, F3 | 51,374 | $77.15 | $3.96M |
| Sale | Class A Common Stock F1, F4 | 12,323 | $78.08 | $962K |
| Sale | Class A Common Stock F1, F5 | 1,500 | $78.57 | $118K |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
Footnotes (11)
- F1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.52 to $76.41, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2), (3), (4), (5), (6), (7), (8), (9), and (10) to this Form 4.
- F3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $76.52 to $77.5, inclusive.
- F4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $77.52 to $78.48, inclusive.
- F5. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $78.55 to $78.64, inclusive.
- F6. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $73.26 to $74.21, inclusive.
- F7. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $74.26 to $75.22, inclusive.
- F8. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $75.28 to $75.95, inclusive.
- F9. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $76.38 to $77.35, inclusive.
- F10. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $77.59 to $77.59, inclusive.
- F11. The option is fully vested and exercisable.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
Class A Common Stock financial
fully vested and exercisable financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did ACMR insider David H. Wang do in this Form 4 filing?
Over what dates did the ACMR insider transactions occur?
How many ACMR options did David H. Wang exercise, and at what price?
Were the ACMR insider sales made under a Rule 10b5-1 trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.